Bartlett & Co. LLC Sells 1,235 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Bartlett & Co. LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.5% during the 1st quarter, Holdings Channel reports. The fund owned 34,519 shares of the pharmacy operator’s stock after selling 1,235 shares during the period. Bartlett & Co. LLC’s holdings in Walgreens Boots Alliance were worth $1,895,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Enterprise Trust & Investment Co increased its stake in shares of Walgreens Boots Alliance by 48.9% in the fourth quarter. Enterprise Trust & Investment Co now owns 75,550 shares of the pharmacy operator’s stock worth $3,623,000 after purchasing an additional 24,800 shares in the last quarter. Cambridge Financial Group Inc. increased its stake in shares of Walgreens Boots Alliance by 8.7% in the fourth quarter. Cambridge Financial Group Inc. now owns 131,126 shares of the pharmacy operator’s stock worth $5,229,000 after purchasing an additional 10,500 shares in the last quarter. Unison Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 1.3% in the fourth quarter. Unison Advisors LLC now owns 42,432 shares of the pharmacy operator’s stock worth $1,693,000 after purchasing an additional 544 shares in the last quarter. Stifel Financial Corp increased its stake in shares of Walgreens Boots Alliance by 19.1% in the fourth quarter. Stifel Financial Corp now owns 1,030,045 shares of the pharmacy operator’s stock worth $41,078,000 after purchasing an additional 165,435 shares in the last quarter. Finally, Equity Investment Corp increased its stake in shares of Walgreens Boots Alliance by 19.1% in the fourth quarter. Equity Investment Corp now owns 1,410,706 shares of the pharmacy operator’s stock worth $56,259,000 after purchasing an additional 225,973 shares in the last quarter. Institutional investors and hedge funds own 55.96% of the company’s stock.

A number of brokerages have recently issued reports on WBA. Robert W. Baird raised shares of Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and increased their price objective for the stock from $41.00 to $55.00 in a research note on Monday, January 11th. Truist Securities increased their price objective on shares of Walgreens Boots Alliance from $50.00 to $58.00 in a research note on Thursday, April 1st. Barclays raised their target price on shares of Walgreens Boots Alliance from $47.00 to $55.00 and gave the company an “equal weight” rating in a research note on Monday, April 5th. Credit Suisse Group raised their target price on shares of Walgreens Boots Alliance from $46.00 to $50.00 and gave the company a “neutral” rating in a research note on Thursday, April 1st. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $38.00 target price for the company in a research note on Monday, January 11th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $49.06.

Shares of NASDAQ:WBA opened at $52.58 on Friday. Walgreens Boots Alliance, Inc. has a 52 week low of $33.36 and a 52 week high of $57.05. The stock has a market capitalization of $45.45 billion, a P/E ratio of 105.16, a PEG ratio of 1.52 and a beta of 0.44. The firm has a fifty day simple moving average of $52.75 and a two-hundred day simple moving average of $45.14. The company has a quick ratio of 0.32, a current ratio of 0.67 and a debt-to-equity ratio of 0.58.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Tuesday, March 30th. The pharmacy operator reported $1.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.30. The firm had revenue of $32.78 billion during the quarter, compared to analyst estimates of $36.16 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The business’s revenue was down 8.5% on a year-over-year basis. During the same quarter last year, the business earned $1.52 EPS. On average, analysts expect that Walgreens Boots Alliance, Inc. will post 4.84 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were issued a $0.4675 dividend. The ex-dividend date was Thursday, February 18th. This represents a $1.87 annualized dividend and a dividend yield of 3.56%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.45%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Further Reading: How to invest in blue-chip stocks

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.